Circulating Tumor DNA Dynamics to Optimize Neoadjuvant Therapy in HER2-Positive and Triple-Negative Breast Cancer
Clinical trial NCT07662252 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07662252
- Sponsor
- Federico II University
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-10-01
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.